Henne Holstege

9.0k total citations
72 papers, 2.8k citations indexed

About

Henne Holstege is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Henne Holstege has authored 72 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 31 papers in Genetics and 22 papers in Physiology. Recurrent topics in Henne Holstege's work include Alzheimer's disease research and treatments (21 papers), Dementia and Cognitive Impairment Research (16 papers) and Genetic Associations and Epidemiology (11 papers). Henne Holstege is often cited by papers focused on Alzheimer's disease research and treatments (21 papers), Dementia and Cognitive Impairment Research (16 papers) and Genetic Associations and Epidemiology (11 papers). Henne Holstege collaborates with scholars based in Netherlands, United States and United Kingdom. Henne Holstege's co-authors include Jos Jonkers, Marcel Reinders, Marc Hulsman, Philip Scheltens, Ron Kerkhoven, Arno Velds, Lodewyk F.A. Wessels, Sven J. van der Lee, Xiaoling Liu and Malcolm J. Low and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Henne Holstege

68 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henne Holstege Netherlands 26 1.3k 691 620 600 366 72 2.8k
Marcelo Páez-Pereda Germany 35 1.4k 1.1× 469 0.7× 222 0.4× 340 0.6× 459 1.3× 85 3.8k
Fernando A. González Spain 30 2.1k 1.6× 385 0.6× 356 0.6× 237 0.4× 200 0.5× 104 3.8k
Christoph Ullmer Switzerland 29 1.8k 1.4× 613 0.9× 407 0.7× 407 0.7× 86 0.2× 69 3.8k
Ling Shan China 32 855 0.7× 576 0.8× 149 0.2× 192 0.3× 345 0.9× 100 2.6k
Yin Li China 28 2.4k 1.9× 1.1k 1.7× 329 0.5× 392 0.7× 1.0k 2.7× 104 4.4k
Ryozo Kuwano Japan 38 2.7k 2.1× 251 0.4× 1.2k 1.9× 783 1.3× 227 0.6× 153 4.6k
Johan Lundkvist Sweden 29 1.6k 1.3× 384 0.6× 830 1.3× 170 0.3× 515 1.4× 51 3.4k
Brett T. Marck United States 27 951 0.7× 153 0.2× 438 0.7× 475 0.8× 653 1.8× 53 3.1k
Daniel R. Premkumar United States 27 956 0.8× 195 0.3× 648 1.0× 141 0.2× 192 0.5× 44 1.9k

Countries citing papers authored by Henne Holstege

Since Specialization
Citations

This map shows the geographic impact of Henne Holstege's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henne Holstege with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henne Holstege more than expected).

Fields of papers citing papers by Henne Holstege

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henne Holstege. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henne Holstege. The network helps show where Henne Holstege may publish in the future.

Co-authorship network of co-authors of Henne Holstege

This figure shows the co-authorship network connecting the top 25 collaborators of Henne Holstege. A scholar is included among the top collaborators of Henne Holstege based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henne Holstege. Henne Holstege is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Sven J. van der, Marc Hulsman, Rosalina van Spaendonk, et al.. (2025). Prevalence of Pathogenic Variants and Eligibility Criteria for Genetic Testing in Patients Who Visit a Memory Clinic. Neurology. 104(4). e210273–e210273. 1 indexed citations
2.
Salazar, Alex, Niccoló Tesi, Yolande A.L. Pijnenburg, et al.. (2024). An AluYb8 mobile element characterises the risk haplotype of the TMEM106B locus associated with neurodegeneration. Alzheimer s & Dementia. 20(S1). e090857–e090857. 1 indexed citations
3.
Tesi, Niccoló, Henne Holstege, Eva Strijbis, et al.. (2024). Association of Polygenic Risk Score With Lifetime Risk of Developing Multiple Sclerosis in a Population-Based Birth-Year Cohort. Neurology. 103(7). e209663–e209663. 2 indexed citations
4.
Zhang, Meng, et al.. (2023). Identifying Aging and Alzheimer Disease–Associated Somatic Variations in Excitatory Neurons From the Human Frontal Cortex. Neurology Genetics. 9(3). e200066–e200066. 2 indexed citations
5.
Teodósio, Cristina, Brigitta A. E. Naber, Sandra A. Vloemans, et al.. (2023). Carriers of the p.P522R variant in PLCγ2 have a slightly more responsive immune system. Molecular Neurodegeneration. 18(1). 25–25. 6 indexed citations
6.
Baker, Emily, Ganna Leonenko, Karl Michael Schmidt, et al.. (2023). What does heritability of Alzheimer’s disease represent?. PLoS ONE. 18(4). e0281440–e0281440. 22 indexed citations
7.
Mol, Merel O., Sven J. van der Lee, Marc Hulsman, et al.. (2022). Mapping the genetic landscape of early-onset Alzheimer’s disease in a cohort of 36 families. Alzheimer s Research & Therapy. 14(1). 77–77. 8 indexed citations
8.
Tesi, Niccoló, Sven J. van der Lee, Marc Hulsman, Henne Holstege, & Marcel Reinders. (2021). snpXplorer: a web application to explore human SNP-associations and annotate SNP-sets. Nucleic Acids Research. 49(W1). W603–W612. 20 indexed citations
9.
Tesi, Niccoló, Marc Hulsman, Iris E. Jansen, et al.. (2021). Pathway-specific polygenic risk score of AD-associated genetic variants associated with AD risk, resilience against AD, and progression to AD. Pure Amsterdam UMC. 1 indexed citations
10.
Pelkmans, Wiesje, Nienke Legdeur, Mara ten Kate, et al.. (2021). Amyloid‐β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest‐old. Annals of Clinical and Translational Neurology. 8(2). 348–358. 11 indexed citations
11.
Tesi, Niccoló, Sven J. van der Lee, Marc Hulsman, et al.. (2020). Immune response and endocytosis pathways are associated with the resilience against Alzheimer’s disease. Translational Psychiatry. 10(1). 332–332. 34 indexed citations
12.
Legdeur, Nienke, Maqsood Yaqub, Nina Beker, et al.. (2020). What Determines Cognitive Functioning in the Oldest-Old? The EMIF-AD 90+ Study. The Journals of Gerontology Series B. 76(8). 1499–1511. 18 indexed citations
13.
Rutten, Julie W., Marco Duering, Gido Gravesteijn, et al.. (2020). Broad phenotype of cysteine-altering NOTCH3 variants in UK Biobank. Publisher. 1 indexed citations
14.
Wong, Tsz Hang, Sven J. van der Lee, Jeroen van Rooij, et al.. (2018). EIF2AK3 variants in Dutch patients with Alzheimer's disease. Neurobiology of Aging. 73. 229.e11–229.e18. 9 indexed citations
15.
Beker, Nina, Marc Hulsman, Sietske A.M. Sikkes, et al.. (2018). Neuropathology and cognitive performance in self-reported cognitively healthy centenarians. Acta Neuropathologica Communications. 6(1). 64–64. 40 indexed citations
16.
Cohn‐Hokke, Petra E., Henne Holstege, Marjan M. Weiss, et al.. (2016). A novel CCM2 variant in a family with non‐progressive cognitive complaints and cerebral microbleeds. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 174(3). 220–226. 4 indexed citations
17.
Louwersheimer, Eva, Alfredo Ramı́rez, Carlos Cruchaga, et al.. (2014). The influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease. Neurobiology of Aging. 36(3). 1605.e13–1605.e20. 29 indexed citations
18.
Evers, Bastiaan, Eva Schut, Eline van der Burg, et al.. (2009). A High-Throughput Pharmaceutical Screen Identifies Compounds with Specific Toxicity against BRCA2-Deficient Tumors. Clinical Cancer Research. 16(1). 99–108. 66 indexed citations
19.
Holstege, Henne, Simon A. Joosse, Conny Th.M. van Oostrom, et al.. (2009). High Incidence of Protein-Truncating TP53 Mutations in BRCA1-Related Breast Cancer. Cancer Research. 69(8). 3625–3633. 124 indexed citations
20.
Liu, Xiaoling, Patrick W.B. Derksen, Bastiaan Evers, et al.. (2005). Conditional mouse models of breast cancer. Cancer Research. 65. 250–251. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcelo Páez-Pereda Breakdown of academic impact, for papers by Fernando A. González Breakdown of academic impact, for papers by Christoph Ullmer Breakdown of academic impact, for papers by Ling Shan Breakdown of academic impact, for papers by Yin Li Breakdown of academic impact, for papers by Ryozo Kuwano Breakdown of academic impact, for papers by Johan Lundkvist Breakdown of academic impact, for papers by Brett T. Marck Breakdown of academic impact, for papers by Daniel R. Premkumar
Rankless by CCL
2026